Skip to content
Faron, etusivu
Careers
For Patients
Contact Information
Search for:
LANGUAGE
English
Suomi
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
Newsroom
Releases and announcements
Reports and presentations
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Share monitor
Shareholders
Management ownership and transactions
Option plans and Warrants
Public offering 2024
Rights Offering 2026
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
Newsroom
Releases and announcements
Reports and presentations
Careers
For Patients
Contact Information
Search for:
LANGUAGE
English
Suomi
releases and announcements
Category
All
Company announcements
Press releases
Managers' transactions
Flagging notifications
Year
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
10.05.2021
Holding(s) in Company
Shareholder announcement
Regulatory
29.04.2021
Grant of options
Insider Transaction
Regulatory
23.04.2021
Board Change
Regulatory
23.04.2021
Result of AGM
Regulatory
29.03.2021
Appointment of a Broker
Regulatory
25.03.2021
Exercise of Options
Regulatory
25.03.2021
Notice of Faron Pharmaceuticals Ltd’s AGM
Regulatory
25.03.2021
Faron´s Annual Report 2020 published
Regulatory
25.03.2021
Financial statement January 1 to December 31 2020
Regulatory
22.03.2021
Bexmarilimab (Clevegen) development update
Regulatory
Previous
Next
Back to top
